Company Filing History:
Years Active: 2013-2014
Title: Innovator Spotlight: Eric Steven Manas
Introduction: Eric Steven Manas, located in King of Prussia, Pennsylvania, is a notable inventor with a focus on pharmaceutical innovations. With two patents to his name, he has made significant contributions to the field of medicinal chemistry.
Latest Patents: Among his most recent inventions are two notable patents related to TRPV4 antagonists. The first patent pertains to quinoline analogs, pharmaceutical compositions containing these compounds, and their application as TRPV4 antagonists. The second patent involves diazabicyclo[2.2.1]hept-2-yl analogs, also detailing the pharmaceutical compositions and their utility as TRPV4 antagonists. These patents showcase Eric's expertise in drug development and innovation.
Career Highlights: Eric is currently employed at GlaxoSmithKline LLC, where he continues to advance research in pharmaceutical sciences. His work at a leading global healthcare company reflects his commitment to improving health outcomes through innovative medication solutions.
Collaborations: Eric has collaborated with esteemed colleagues such as Mui Cheung and Hilary Schenck Eidam, contributing to a dynamic team focused on research excellence and product development in the pharmaceutical industry.
Conclusion: Eric Steven Manas stands out as an accomplished inventor in the realm of pharmaceuticals. His patents not only highlight his ingenuity but also serve as a testament to his dedication to enhancing medical treatment options. As he continues his work at GlaxoSmithKline LLC, his contributions are likely to have a lasting impact on healthcare advancements.